{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:40:41Z","timestamp":1763037641421,"version":"3.45.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:00:00Z","timestamp":1628208000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cientifico e Tecnologico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis Plus"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.athplu.2021.08.001","type":"journal-article","created":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T05:11:27Z","timestamp":1628399487000},"page":"3-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Familial hypercholesterolemia and COVID-19: A menacing but treatable vasculopathic condition"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5504-2959","authenticated-orcid":false,"given":"Alpo","family":"Vuorio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timo E.","family":"Strandberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9170-7938","authenticated-orcid":false,"given":"Frederik","family":"Raal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9860-6582","authenticated-orcid":false,"given":"Raul D.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petri T.","family":"Kovanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.athplu.2021.08.001_bib1","doi-asserted-by":"crossref","first-page":"154408","DOI":"10.1016\/j.metabol.2020.154408","article-title":"Commentary: COVID-19 and obesity pandemics converge into a syndemic requiring urgent and multidisciplinary action","volume":"114","author":"Hill","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.athplu.2021.08.001_bib2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMc2018688","article-title":"New-onset diabetes in covid-19","volume":"383","author":"Rubino","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.athplu.2021.08.001_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41574-020-00449-y","article-title":"COVID-19 alters thinking and management in metabolic diseases","volume":"17","author":"le Roux","year":"2021","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"10.1016\/j.athplu.2021.08.001_bib4","doi-asserted-by":"crossref","first-page":"6350","DOI":"10.1038\/s41598-021-85788-0","article-title":"Metabolomics analysis reveals a modified amino acid metabolism that correlates with altered oxygen homeostasis in COVID-19 patients","volume":"18","author":"P\u00e1ez-Franco","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.athplu.2021.08.001_bib5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s13054-020-03062-7","article-title":"The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection","volume":"24","author":"Pons","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.athplu.2021.08.001_bib6","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1093\/eurheartj\/ehaa623","article-title":"COVID-19 is, in the end, an endothelial disease","volume":"41","author":"Libby","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.athplu.2021.08.001_bib7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jacl.2020.06.006","article-title":"Prevention of endothelial dysfunction and thrombotic events in COVID-19 patients with familial hypercholesterolemia","volume":"14","author":"Vuorio","year":"2020","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.athplu.2021.08.001_bib8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/his.14134","article-title":"Post-mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction","volume":"77","author":"Menter","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.athplu.2021.08.001_bib9","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1016\/j.jacc.2020.03.057","article-title":"Worldwide prevalence of familial hypercholesterolemia: meta-analyses of 11 million subjects","volume":"75","author":"Beheshti","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.athplu.2021.08.001_bib10","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1161\/01.ATV.17.11.3332","article-title":"Neonatal diagnosis of familial hypercholesterolemia in newborns born to a parent with a molecularly defined heterozygous familial hypercholesterolemia","volume":"17","author":"Vuorio","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.athplu.2021.08.001_bib11","first-page":"CD006401","article-title":"Statins for children with familial hypercholesterolemia","author":"Vuorio","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.athplu.2021.08.001_bib12","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.atherosclerosis.2012.02.019","article-title":"Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment","volume":"223","author":"Raal","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.athplu.2021.08.001_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2021.01.021","article-title":"Familial hypercholesterolaemia and COVID-19: a two-hit scenario for endothelial dysfunction amenable to treatment","volume":"320","author":"Vuorio","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.athplu.2021.08.001_bib14","article-title":"COVID-19 associated risks of myocardial infarction in persons with familial hypercholesterolemia with or without","volume":"7","author":"Myers","year":"2021","journal-title":"ASCVD Am J Prev Cardiol"},{"year":"2020","series-title":"Host metabolic reprogramming in response to SARS-CoV-2 infection [preprint]","author":"Moolamalla","key":"10.1016\/j.athplu.2021.08.001_bib15"},{"key":"10.1016\/j.athplu.2021.08.001_bib16","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.145027","article-title":"Metabolic reprogramming and epigenetic changes of vital organs in SARS-CoV-2-induced systemic toxicity","volume":"6","author":"Li","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.athplu.2021.08.001_bib17","doi-asserted-by":"crossref","first-page":"9110","DOI":"10.1038\/s41598-017-09536-z","article-title":"Altered lipid metabolism in recovered SARS patients twelve years after infection","volume":"7","author":"Wu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.athplu.2021.08.001_bib18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/sj.gene.6363883","article-title":"Association of low-density lipoprotein receptor polymorphisms and outcome of hepatitis C infection","volume":"3","author":"Hennig","year":"2002","journal-title":"Gene Immun"},{"key":"10.1016\/j.athplu.2021.08.001_bib19","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.tem.2021.01.001","article-title":"Altered cholesterol and lipid synthesis mediates hyperinflammation in COVID-19","volume":"32","author":"Sohrabi","year":"2021","journal-title":"Trends Endocrinol Metabol"},{"key":"10.1016\/j.athplu.2021.08.001_bib20","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.gene.2012.02.031","article-title":"The impact of severe LDL receptor mutations on SREBP-pathway regulation in homozygous familial hypercholesterolemia (FH)","volume":"499","author":"Soufi","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.athplu.2021.08.001_bib21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1172\/JCI116983","article-title":"Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level","volume":"93","author":"Sorensen","year":"1994","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.athplu.2021.08.001_bib22","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.atherosclerosis.2008.09.025","article-title":"Inflammatory and thrombotic processes are associated with vascular dysfunction in children with familial hypercholesterolemia","volume":"204","author":"Charakida","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.athplu.2021.08.001_bib23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11883-020-00867-3","article-title":"Lipoprotein(a) and its potential association with thrombosis and inflammation in COVID-19: a testable hypothesis","volume":"22","author":"Moriarty","year":"2020","journal-title":"Curr Atherosclerosis Rep"},{"key":"10.1016\/j.athplu.2021.08.001_bib24","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1073\/pnas.90.4.1369","article-title":"5' control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family","volume":"90","author":"Wade","year":"1993","journal-title":"Proc Natl Acad Sci Unit States Am"},{"key":"10.1016\/j.athplu.2021.08.001_bib25","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1006\/cyto.2002.1044","article-title":"IL-6 and lipoprotein(a) [LP(a)] concentrations are related only in patients with high APO(a) isoforms in monoclonal gammopathy","volume":"18","author":"Horv\u00e1th","year":"2002","journal-title":"Cytokine"},{"key":"10.1016\/j.athplu.2021.08.001_bib26","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.athplu.2021.08.001_bib27","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.atherosclerosis.2010.06.006","article-title":"Acute infection with Epstein-Barr virus is associated with atherogenic lipid changes","volume":"212","author":"Apostolou","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.athplu.2021.08.001_bib28","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1161\/CIRCRESAHA.114.302355","article-title":"Atherosclerotic plaque destabilization: mechanisms, models, and therapeutic strategies","volume":"114","author":"Silvestre-Roig","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.athplu.2021.08.001_bib29","article-title":"Lipoprotein(a) and SARS-CoV-2 infections: susceptibility to infections, ischemic heart disease and thromboembolic events [published online ahead of print, 2021 Jun 7]","author":"Di Maio","year":"2021","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.athplu.2021.08.001_bib30","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/joim.13275","article-title":"Arterial stiffness in acute COVID-19 and potential associations with clinical outcome","volume":"290","author":"Schnaubelt","year":"2021","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.athplu.2021.08.001_bib31","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.bjp.0703393","article-title":"Endothelial dysfunction in diabetes","volume":"130","author":"De Vriese","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.athplu.2021.08.001_bib32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1475-2840-13-53","article-title":"High glucose induces human endothelial dysfunction through an Axl-dependent mechanism","volume":"13","author":"Lee","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.athplu.2021.08.001_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001610","article-title":"Pre-impaired fasting glucose state is a risk factor for endothelial dysfunction: flow-mediated Dilation Japan (FMD-J) study","volume":"8","author":"Yamaji","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.athplu.2021.08.001_bib34","article-title":"Endothelial activation and dysfunction in metabolic syndrome, type 2 diabetes and coronavirus disease 2019","volume":"48","author":"Hayden","year":"2020","journal-title":"J\u00a0Int Med Res"},{"key":"10.1016\/j.athplu.2021.08.001_bib35","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/jama.2015.1206","article-title":"Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus","volume":"313","author":"Besseling","year":"2015","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.athplu.2021.08.001_bib36","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/jama.287.5.598","article-title":"Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men: a randomized controlled trial","volume":"287","author":"Jula","year":"2002","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.athplu.2021.08.001_bib37","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.athplu.2021.08.001_bib38","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/joim.12405","article-title":"Statins and new-onset diabetes mellitus \u2013 a risk lacking in familial hypercholesterolaemia","volume":"279","author":"Vuorio","year":"2016","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.athplu.2021.08.001_bib39","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/joim.13070","article-title":"Familial hypercholesterolaemia and COVID-19: triggering of increased sustained cardiovascular risk","volume":"287","author":"Vuorio","year":"2020","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.athplu.2021.08.001_bib40","doi-asserted-by":"crossref","first-page":"579548","DOI":"10.3389\/fphar.2020.579548","article-title":"Statins as adjuvant therapy for COVID-19 to calm the stormy immunothrombosis and beyond","volume":"11","author":"Vuorio","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.athplu.2021.08.001_bib41","article-title":"Effect of statin therapy on SARS-CoV-2 infection-related","author":"Masana","year":"2020","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.athplu.2021.08.001_bib42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/CIRCULATIONAHA.112.145334","article-title":"Statins as antithrombotic drugs","volume":"127","author":"Violi","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.athplu.2021.08.001_bib43a","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.atherosclerosis.2020.09.008","article-title":"Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: an expert panel position statement from HEART UK","volume":"313","author":"Iqbal","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.athplu.2021.08.001_bib43b","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/joim.12981","article-title":"Familial hypercholesterolemia and elevated lipoprotein(a): double heritable risk and new therapeutic opportunities","volume":"287","author":"Vuorio","year":"2020","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.athplu.2021.08.001_bib44","article-title":"Myocarditis with COVID-19 mRNA vaccines [published online ahead of print, 2021 Jul 20]","author":"Bozkurt","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.athplu.2021.08.001_bib45","article-title":"Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military [published online ahead of print, 2021 Jun 29]","author":"Montgomery","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.athplu.2021.08.001_bib46","article-title":"COVID-19 mRNA vaccine and myocarditis","volume":"8","author":"Singh","year":"2021","journal-title":"Eur J Case Rep Intern Med"},{"key":"10.1016\/j.athplu.2021.08.001_bib47","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/joim.13210","article-title":"PCSK9 inhibitors for COVID-19: an opportunity to enhance the antiviral action of interferon in patients with hypercholesterolaemia","volume":"289","author":"Vuorio","year":"2021","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.athplu.2021.08.001_bib48","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/jamia\/ocaa246","article-title":"A\u00a0Bayesian framework for estimating the risk ratio of hospitalization for people with comorbidity infected by SARS-CoV-2 virus","volume":"28","author":"Gao","year":"2021","journal-title":"J\u00a0Am Med Inf Assoc"},{"key":"10.1016\/j.athplu.2021.08.001_bib49","doi-asserted-by":"crossref","first-page":"100224","DOI":"10.1016\/j.ajpc.2021.100224","article-title":"Patients with familial hypercholesterolemia and COVID-19: efficient and ongoing cholesterol lowering is paramount for the prevention of acute myocardial infarction","volume":"7","author":"Kovanen","year":"2021","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.athplu.2021.08.001_bib50","doi-asserted-by":"crossref","first-page":"669373","DOI":"10.3389\/fgene.2021.669373","article-title":"Editorial: genetics of familial hypercholesterolemia: new insight","volume":"12","author":"Vuorio","year":"2021","journal-title":"Front Genet"}],"container-title":["Atherosclerosis Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667089521000237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667089521000237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T08:42:51Z","timestamp":1763023371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667089521000237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":51,"alternative-id":["S2667089521000237"],"URL":"https:\/\/doi.org\/10.1016\/j.athplu.2021.08.001","relation":{},"ISSN":["2667-0895"],"issn-type":[{"type":"print","value":"2667-0895"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Familial hypercholesterolemia and COVID-19: A menacing but treatable vasculopathic condition","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis Plus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.athplu.2021.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}